Aurobindo Pharma Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:	524804	NSE Symbol:	AUROPHARMA	P/E :	34.31
ISIN Demat:	INE406A01037	Div & Yield %:	0	EPS :	34.79
Book Value:	369.16	Market Cap (Rs. Cr.):	69,330.29	Face Value :	1

Date	Headline
14-Nov-25	USFDA issues EIR for Unit 1 of Apitoria Pharma
25-Oct-25	Aurobindo Pharma announces board meeting date
01-Oct-25	Aurobindo Pharma announces change in senior management
26-Aug-25	CuraTeQ Biologics receives UK MHRA approval for Dazublys™
13-Aug-25	Aurobindo Pharma AGM scheduled
04-Aug-25	Board of Aurobindo Pharma recommends interim dividend
24-Jul-25	Aurobindo Pharma to hold board meeting
02-Jul-25	CuraTeQ Biologics receives European marketing authorization for biosimilar Dazublys™
30-Jun-25	Lyfius Pharma re-starts production at its Penicillin-G manufacturing facility
24-Jun-25	CuraTeQ Biologics receives UK MHRA approval for biosimilar Dyrupeg™

Company Snapshot